The researchers took T cells from the tumour, removed PD-1, multiplied the T cells and put them back into the mice and found that the tumours shrank.
They then inserted the enzyme and found that these T cells were able to keep up the fight at the tumour site.
The team is preparing for clinical trials and has started a company, PanTher Therapeutics, to develop the implant for patient use.
Read more
Comments are closed.